A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos

In 2018, Chinese scientist He Jiankui faced global criticism and imprisonment for creating the first gene-edited babies. Despite this, biotech entrepreneur Cathy Tie, founder of Origin Genomics, advocates for gene-edited embryos, calling it a “moral imperative.” Her company aims to introduce gene-edited embryos to IVF clinics, seeking public funding and regulatory support. However, safety concerns persist, as gene editing could introduce new health risks passed to future generations. Critics argue that existing genetic screening in IVF is sufficient, though it can be inefficient, as seen in the case of Ian Watts and Cheyenne Ziegler, who struggled to produce embryos free of a genetic disorder. The debate continues over the necessity and ethics of gene-editing embryos, with potential implications for future generations. QUESTION: How might the development of gene-edited embryos impact the future of family planning and genetic disease prevention?